Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etodolac-lidocaine patch for acute DOMS
NCT02695381Phase 3Completed
- Sponsor
- MEDRx
- Start
- Mar 2016
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of etodolac + lidocaine in delayed onset muscle soreness (DOMS), sponsored by MEDRx. Started Mar 2016; status: completed.
02
Drugs
etodolac + lidocaine
03
Conditions
delayed onset muscle soreness (DOMS)
Beyond the preview
Go deeper on NCT02695381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02695381.